ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325M; ADCT Will Sell Sells Capped Royalty Interest On ZYNLONTA And Cami For $225M Upon Closing With An Additional $100M In Potential Near-term Milestone Payments